The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
about
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood TransplantationDynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention.Upper gastrointestinal acute graft--host disease adds minimal prognostic value in isolation or with other graft--host disease symptoms as currently diagnosed and treated
P2860
Q34272554-53833366-E382-470A-8DD8-D28684256D29Q38849186-09D86665-108B-4C2A-867E-B430A98B8295Q39116985-F13F38CE-4E4F-4B48-97C9-2618A9E2336AQ40342288-B11AE32A-B883-4BC2-8EA2-05B3C9CAF68CQ40386808-213067CA-6C15-4E4F-8380-8D831FE110E7Q40577820-4A266977-80E2-40B0-A9E6-D7C4100B579AQ45074498-D95F7568-B6FF-43D6-82EC-DD776B07A080Q47197124-3D8224B5-C3C6-42A3-BDE7-8E0278392AEDQ47603352-9C63DCCD-5FD1-46A1-B636-6A748ADB76AEQ48337187-ECFDBCAB-4839-419D-8CD3-EE57351BB5D0Q58793795-994C6A0E-4A6C-4EB7-8C5F-2582BEA50617
P2860
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The addition of sirolimus to t ...... a multicentre randomized trial
@ast
The addition of sirolimus to t ...... a multicentre randomized trial
@en
type
label
The addition of sirolimus to t ...... a multicentre randomized trial
@ast
The addition of sirolimus to t ...... a multicentre randomized trial
@en
prefLabel
The addition of sirolimus to t ...... a multicentre randomized trial
@ast
The addition of sirolimus to t ...... a multicentre randomized trial
@en
P2093
P2860
P356
P1476
The addition of sirolimus to t ...... a multicentre randomized trial
@en
P2093
Alex F Herrera
Angela A Giardino
Corey Cutler
Edmund K Waller
Edwin P Alyea
Haesook T Kim
John Koreth
Joseph H Antin
Marie-Michele Sainvil
Neera Jagirdar
P2860
P304
P356
10.1111/BJH.13931
P407
P577
2016-01-05T00:00:00Z